Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy.

Area of Science:

• Neurology
• Infectious Diseases
• Biochemistry

Background:

• Transmissible spongiform encephalopathies (TSEs) pose significant public health challenges.
• Current diagnostic methods for TSEs often rely on post-mortem analysis or invasive procedures.
• The development of reliable blood-based screening tests for TSEs is highly desirable.

Purpose of the Study:

• To review recent advances in blood infectivity, removal, and screening for TSEs.
• To assess the feasibility of detecting the misfolded prion protein (PrP(TSE)) in blood.
• To predict the availability of preclinical and symptomatic blood screening tests for human TSEs.

Main Methods:

• Review of recent scientific literature and advancements in TSE diagnostics.
• Analysis of progress in detecting the diagnostic misfolded prion protein (PrP(TSE)) in blood.
• Evaluation of the potential for blood screening test development.

Main Results:

• Significant progress has been made in blood infectivity and infectivity removal techniques.
• Blood screening tests for TSEs have advanced considerably.
• Reliable detection of PrP(TSE) in blood during the symptomatic phase is anticipated.
• Detection of PrP(TSE) in preclinical stages is highly probable in a proportion of infected individuals.

Conclusions:

• Blood screening tests for TSEs are nearing a critical breakthrough.
• The detection of PrP(TSE) in blood will revolutionize early diagnosis and disease management.
• Anticipated availability of these tests before the end of 2005 represents a major scientific achievement.